Drawing for FAIRPHARM

USPTO serial 78147319

FAIRPHARM

Reviewed by CopyMark Law Group

Reg. 2879110Status 710
Filing date
Status date
Registration date
Aug 31, 2004
Examiner
THOMAS, AMY E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FAIRPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patricia E. McQueeney

PATRICIA E MCQUEENEY BECKER & POLIAKOFF, PA3111 STIRLING RDFT LAUDERDALE, FL 33312UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Deodorant soaps, medicated soap, skin soap, toilet soap, waterless soap, essential oils for personal use, essential oils for industrial use, cosmetics, hair lotions, dentifriceSECTION 8 - CANCELLED
005Pharmaceutical, medical, and veterinary preparations, namely, weight reducing substances, anorectic substances, analeptics, preparations for the treatment of hypoxemia, analgesics, antirheumatics, antiallergenics, antianemics, antiarrhythmics, preparations for the treatment of dementia, nootropics, antienemics, antivertiginous drugs, antiinflammatory agents, antitussive substances, expectorants, preparations for the treatment of arteriosclerosis, balneotherapeutics and preparations for heat therapy, broncholytic agents, antiasthmatics, cholagogue and bile-duct therapeutics, corticoids, dermatics, disinfectants, antiseptics, dietetics, diagnostic preparations for clinical or medical laboratory use, diuretics, preparations for the stimulation of blood circulation, enzyme inhibitors, preparations for the treatment of enzyme deficiency and transport proteins, geriatric agents for the treatment of stress, geriatric nutritional supplements, preparations for the treatment of gout, preparations for the treatment of cold and flu, preparations for the treatment of hemorrhoids, hepatics, hypnotics, sedatives, immunomodulators, cardiac agents, laxatives, agents for lowering lipid levels, agents for the treatment of gastric and intestinal diseases, preparations for the treatment of migraine, mineral supplements, therapeutic agents for treatment of mouth and pharyngeal disease, muscle relaxants, preparations for the treatment of osteoporosis, regulators of calcium metabolism, preparations for the treatment of otological diseases, rhinological preparations, preparations for the treatment of sinusitis, roborants, nutritional supplements in the form of a tonic, thrombocyte aggregation inhibitors, urological preparations, venous therapeutics, vitamins; pharmaceutical preparations, namely, dietary preparations containing vitamin, mineral and trace elements and combinations thereof for supplementing foods; nutraceuticals for use as a dietary supplement; preparations for health care, namely, preparations and nutraceuticals containing vitamins, minerals, and trace elements, and combinations thereof; dietetic substances adapted for sanitary purposes, namely, dietary food supplements in particular with added vitamins; vitamin, mineral and trace element preparations and combinations thereof; plant-based preparations in the form of herbal teas for medicinal purposes and preparations, namely, herbal supplements made from plant extracts and combinations thereof; food supplements adapted for medical use; antibacterial soap; dietary drink mix for use as a food replacement; nutritional drink mix for use as a food replacement; dietary food supplements based on vitamins, minerals, and trace elements, and combinations thereof, including the aforesaid goods where possible in the form of effervescent tablets and for making non-alcoholic beverages; food supplements not adapted for medical useSECTION 8 - CANCELLED
032Mineral and aerated waters and other non-alcoholic drinks, namely, fruit drinks, carbonated soft drinks, low calorie soft drinks and non-carbonated soft drinks; effervescent tablets and other preparations for making non-alcoholic beverages, namely, fruit drinks, soft drinks and low-calorie soft drinksSECTION 8 - CANCELLED
035Online e-commerce provider services, namely, retail shop services featuring vitamins, minerals, trace elements, nutraceuticals, food supplements, pharmaceuticals, health care preparations, dietetic substances, veterinary preparations, herbal supplements, mineral and aerated waters and non-alcoholic drinks, soaps, essential oils, cosmetics, hair lotions, dentrifices; computerized online ordering services in the field of vitamins, minerals, trace elements, nutraceuticals, food supplements, pharmaceuticals, health care preparations, dietetic substances, veterinary preparations, herbal supplements, mineral and aerated waters and non-alcoholic drinks, soaps, essential oils, cosmetics, hair lotions, dentrificesSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 1, 2011C8..CANCELLED SEC. 8 (6-YR)
Aug 31, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 8, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 19, 2004NPUBNOTICE OF PUBLICATION
Feb 10, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2004CNEAEXAMINERS AMENDMENT MAILED
Dec 30, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 15, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 17, 2003CFITCASE FILE IN TICRS
Aug 28, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2003DOCKASSIGNED TO EXAMINER
Jul 26, 2002MAILPAPER RECEIVED

Frequently asked questions

Related guidance